Portfolio Building Block World Pharma and Biotech Index ETF

1. 01

   Volume 3.6× its 30-session average on 4 Nov 2026

   4 Nov 2026 volume of 707.2K shares was 3.6× the average of the 30 sessions before it (198.8K), as the price rose 2.8%. SPY traded 1.5× its own average that session.

   Daily volume against a 30-session baseline · as of 4 Nov 2026

2. 02

   Ahead of SPY over 3 months

   1 month: +14.3% (SPY −1.6%). 3 months: +16.2% (SPY −0.4%). Price change to the 4 Nov 2026 close; dividends excluded.

   Daily closes, split-adjusted: PBPH, SPY · as of 4 Nov 2026

3. 03

   Above its 50- and 200-day averages

   The 4 Nov 2026 close of $31.81 was 9.8% above its 50-day average ($28.96) and 18.0% above its 200-day average ($26.95).

   Daily closes, split-adjusted; 50- and 200-session simple averages · as of 4 Nov 2026

4. 04

   RSI(14) at 73.5, 70 or above

   The 14-session relative strength index closed at 73.5 on 4 Nov 2026, its 1st session at 70 or above. By convention a reading of 70 or above is called overbought and 30 or below oversold.

   Daily closes, split-adjusted; Wilder's 14-session RSI · as of 4 Nov 2026

5. 05

   14.8K shares sold short

   14.8K shares were sold short at the 15 Oct 2026 settlement; covering them would take 1.0 days of average volume. Short interest is reported twice a month, on a lag.

   Exchange short-interest filing · as of 15 Oct 2026

At the 4 Nov 2026 close